Fen-Phen User Fairly Denied Extra Benefits, 3rd Circ. Finds

Law360, Philadelphia (May 22, 2013, 3:46 PM EDT) -- The Third Circuit on Tuesday ruled that the trust overseeing a national class action settlement over the drug combination fen-phen is correctly interpreting a key aspect of the agreement, rejecting a claim by a woman who sought to increase her level of benefits.

The court concluded that the AHP Settlement Trust was not bound by any time limits when weighing evidence to determine whether other factors beyond the use of the drug also led to class members' contraction of heart disease, rejecting claimant Patricia Haberman's argument...
To view the full article, register now.